
Insights, evidence, and real-world results
Explore how hospitals are using PERISCOPE® to support earlier risk identification, backed by clinical validation and peer-reviewed research.
News
The latest updates from Healthplus.ai, including company milestones, partnerships, and industry developments.

Bart Steverink
CTO & Co-founder

PERISCOPE® approved for the European market

Maryse Wiewel
Product Owner

Healthplus.ai wins CES 2024 Innovation Award with PERISCOPE

Bart Geerts
CEO & Co-founder

Healthplus.ai wins health innovation award
Load More

Bart Steverink
CTO & Co-founder

PERISCOPE® approved for the European market

Maryse Wiewel
Product Owner

Healthplus.ai wins CES 2024 Innovation Award with PERISCOPE

Bart Geerts
CEO & Co-founder

Healthplus.ai wins health innovation award

Bart Geerts
CEO & Co-founder

Healthplus.ai receives mentions and nominations to start 2023
Load More
Clinical Evidence
The clinical foundation for PERISCOPE®. Explore validation studies, performance data, and evidence from academic medical centers including Mayo Clinic.
Source
BMJ Open
2025

C-reactive protein in the first 30 postoperative days and its discriminative value as a marker for postoperative infections, a multicentre cohort study
Source
JMIR Medical Informatics
2024

Automated Identification of Postoperative Infections to Allow Prediction and Surveillance Based on Electronic Health Record Data: Scoping Review
Source
The Lancet Regional Health–Europe
2024

Development and validation of artificial intelligence models for early detection of postoperative infections (PERISCOPE): a multicentre study using electronic health record data
Load More
Source
BMJ Open
2025

C-reactive protein in the first 30 postoperative days and its discriminative value as a marker for postoperative infections, a multicentre cohort study
Source
JMIR Medical Informatics
2024

Automated Identification of Postoperative Infections to Allow Prediction and Surveillance Based on Electronic Health Record Data: Scoping Review
Source
The Lancet Regional Health–Europe
2024

Development and validation of artificial intelligence models for early detection of postoperative infections (PERISCOPE): a multicentre study using electronic health record data
Source
PLoS One
2024

Systematic evaluation of machine learning models for postoperative surgical site infection prediction
Load More
News & press
For interview requests, company information, or press materials, we are happy to help. We can connect you with clinical experts, provide background on PERISCOPE® and infection prevention, or share our latest news.

News & press
For interview requests, company information, or press materials, we are happy to help. We can connect you with clinical experts, provide background on PERISCOPE® and infection prevention, or share our latest news.

News & press
For interview requests, company information, or press materials, we are happy to help. We can connect you with clinical experts, provide background on PERISCOPE® and infection prevention, or share our latest news.

Insights
Practical insights on clinical AI, infection prevention, and implementing decision-support tools in hospital workflows. Written by our team and clinical partners.
Events
Meet the Healthplus.ai team at conferences, workshops, and speaking engagements across Europe and beyond. We're happy to connect in person.
Questions you might have
How does PERISCOPE® integrate with our existing EHR?
PERISCOPE® is designed for seamless EHR integration. It processes patient data directly from your existing systems, with no additional data entry required from clinical staff. Our technical team works closely with your IT department to ensure smooth implementation.
How does PERISCOPE® integrate with our existing EHR?
PERISCOPE® is designed for seamless EHR integration. It processes patient data directly from your existing systems, with no additional data entry required from clinical staff. Our technical team works closely with your IT department to ensure smooth implementation.
How does PERISCOPE® integrate with our existing EHR?
PERISCOPE® is designed for seamless EHR integration. It processes patient data directly from your existing systems, with no additional data entry required from clinical staff. Our technical team works closely with your IT department to ensure smooth implementation.
What does the implementation process look like?
Implementation typically includes a technical integration phase, hospital-specific calibration to your patient population, and training for clinical staff. We provide vendor-managed support throughout the process, minimizing the burden on your IT team.
What does the implementation process look like?
Implementation typically includes a technical integration phase, hospital-specific calibration to your patient population, and training for clinical staff. We provide vendor-managed support throughout the process, minimizing the burden on your IT team.
What does the implementation process look like?
Implementation typically includes a technical integration phase, hospital-specific calibration to your patient population, and training for clinical staff. We provide vendor-managed support throughout the process, minimizing the burden on your IT team.
How is PERISCOPE® validated?
PERISCOPE® is a CE-certified Class IIa medical device, validated at academic medical centers including Mayo Clinic. Our prediction models meet a minimum AUROC threshold of 0.7 before being deployed for any surgical specialty.
How is PERISCOPE® validated?
PERISCOPE® is a CE-certified Class IIa medical device, validated at academic medical centers including Mayo Clinic. Our prediction models meet a minimum AUROC threshold of 0.7 before being deployed for any surgical specialty.
How is PERISCOPE® validated?
PERISCOPE® is a CE-certified Class IIa medical device, validated at academic medical centers including Mayo Clinic. Our prediction models meet a minimum AUROC threshold of 0.7 before being deployed for any surgical specialty.
What infections does PERISCOPE® predict?
PERISCOPE® predicts the probability of requiring clinical action related to postoperative bacterial infections. This includes surgical site infections, pneumonia, urinary tract infections, and other bacterial infections occurring within 7 or 30 days after surgery.
What infections does PERISCOPE® predict?
PERISCOPE® predicts the probability of requiring clinical action related to postoperative bacterial infections. This includes surgical site infections, pneumonia, urinary tract infections, and other bacterial infections occurring within 7 or 30 days after surgery.
What infections does PERISCOPE® predict?
PERISCOPE® predicts the probability of requiring clinical action related to postoperative bacterial infections. This includes surgical site infections, pneumonia, urinary tract infections, and other bacterial infections occurring within 7 or 30 days after surgery.
Does PERISCOPE® replace clinical judgment?
No. PERISCOPE® is a clinical decision-support tool that provides additional information to support healthcare professionals. It is always intended to complement, not replace, clinical expertise, hospital protocols, and other sources of information.
Does PERISCOPE® replace clinical judgment?
No. PERISCOPE® is a clinical decision-support tool that provides additional information to support healthcare professionals. It is always intended to complement, not replace, clinical expertise, hospital protocols, and other sources of information.
Does PERISCOPE® replace clinical judgment?
No. PERISCOPE® is a clinical decision-support tool that provides additional information to support healthcare professionals. It is always intended to complement, not replace, clinical expertise, hospital protocols, and other sources of information.






